Tivantinib

Contact us
TargetMol
Product Code: TAR-T6117
Supplier: TargetMol
CodeSizePrice
TAR-T6117-5mg5mg£108.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6117-1mL1 mL * 10 mM (in DMSO)£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6117-10mg10mg£128.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6117-25mg25mg£185.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6117-50mg50mg£258.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6117-100mg100mg£365.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6117-200mg200mg£550.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1
❮❯

Documents

Further Information

Bioactivity:
Tivantinib is an orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity.
CAS:
905854-02-6
Formula:
C23H19N3O2
Molecular Weight:
369.424
Pathway:
Tyrosine Kinase/Adaptors; Apoptosis
Purity:
0.9995
SMILES:
O=C1NC(=O)[C@H]([C@@H]1c1c[nH]c2ccccc12)c1cn2CCCc3cccc1c23
Target:
Apoptosis; c-Met/HGFR

References

Comoglio PM, et al. Nat Rev Drug Discov, 2008, 7(6), 504-516. Munshi N, et al. Mol Cancer Ther. 2010, 9(6), 1544-1553. Huang Y, Guo Y, Zhou Y, et al.Tivantinib alleviates inflammatory diseases by directly targeting NLRP3.iScience.2023